Zhao, L.

panobinostat patient quality period product study consumer firm f trade profit table import inspection phase ketoconazole market increase production inhibitor error sabotage ch cl cyp 3a inhibitor extension phase country result difference parameter incentive sample core phase tainting investment period 1 treatment export welfare tariff cancer firm h condition model pharmacokinetic experience testing activity analysis trading system cyp 3a government safety hypophosphatemia phosphate i 1 c cyp 3a inhibitors extension type i error value probability tumor institute proposition exporter example interaction paper effect price x 2 h event histone information fi rst dose trial type ii error economic sabotage activities class journal ratio